The plant in Wilson specializes in the formulation, syringe filling, and packaging of aseptic and terminally sterilized drug products and diluents with the advantage of being able to offer large-scale quantities and flexibility in the syringe portfolio and sizes. PFS drug products and diluents are produced on fully automated manufacturing, inspection, and packaging lines in a continuous process under controlled conditions. This highly automated and state-of-the-art manufacturing facility has a unique capability and capacity to launch hundreds of millions of new and existing commercial PFS drug products including biologics, highly active compounds and products (maximum OEL = 1 µg/m3), and products that are sensitive to temperature, light, and/or oxygen.
Highly active compounds, products and biologics can be formulated and filled using modern disposable, single-use system technologies that employ fully disposable or dedicated product contact components to minimize exposure. Products sensitive to oxygen can undergo nitrogen-filling technologies with light-protected palletization to achieve maximum shelf life and market value. All lines are installed with serialization and aggregation (track-and-trace) equipment to meet U.S. DSCSA requirements.